July 27, 2020
July 27, 2020 –
The U.S. FDA has approved XeglyzeTM (abametapir 0.74% lotion), manufactured by Dr.
Reddy’s Laboratories, as a topical treatment for head lice infestation in
July 27, 2020
July 27, 2020 –
The U.S. FDA has approved Amneal Pharmaceuticals’ generic version of Demser®
(metyrosine – Valeant Pharmaceutical) oral capsules. Metyrosine is indicated
July 24, 2020
July 24, 2020 –
The U.S. FDA has approved Onureg® (azacitidine) tablets, manufactured by Bristol-Myers
Squibb, to provide continued treatment for adults diagnosed with acute myeloid
July 24, 2020
July 24, 2020 –
The U.S. FDA has approved Breztri AerosphereTM (budesonide/glycopyrrolate/formoterol fumarate), manufactured by AstraZeneca, to provide maintenance treatment
July 24, 2020
July 24, 2020 –
The U.S. FDA has approved an expanded indication for VecticalTM (calcitriol) topical
ointment, manufactured by Galderma Laboratories, to treat mild to
July 1, 2020
July 31, 2020 –
The U.S. FDA has approved an expanded indication for Evotaz® (atazanavir/cobicistat) oral
tablets, manufactured by Bristol-Myers Squibb, to include its use in
July 1, 2020
July 31, 2020 –
The U.S. FDA has approved a new indication for Epidiolex® (cannabidiol) oral solution,
manufactured by GW Pharmaceuticals. The drug is now indicated to
July 1, 2020
July 31, 2020 –
The U.S. FDA has approved an expanded indication for Prezcobix® (darunavir/cobicistat)
oral tablets, manufactured by Janssen Pharmaceuticals. The product is